Session

H. pylori (Posters)

OPTIMIZATION OF VONOPRAZAN-AMOXICILLIN DUAL THERAPY FOR ERADICATING HELICOBACTER PYLORI INFECTION IN CHINA: A PROSPECTIVE, RANDOMIZED CLINICAL PILOT STUDY
OPTIMIZATION OF VONOPRAZAN-AMOXICILLIN DUAL THERAPY FOR ERADICATING HELICOBACTER PYLORI INFECTION IN CHINA: A PROSPECTIVE, RANDOMIZED CLINICAL PILOT STUDY

EVALUATION OF THE ACCURACY OF THE "LIAISON(R) MERIDIAN HELICOBACTER PYLORI SA" STOOL ANTIGEN TEST FOR THE DIAGNOSIS OF H. PYLORI INFECTION: A SPANISH MULTICENTRE STUDY
EVALUATION OF THE ACCURACY OF THE "LIAISON(R) MERIDIAN HELICOBACTER PYLORI SA" STOOL ANTIGEN TEST FOR THE DIAGNOSIS OF H. PYLORI INFECTION: A SPANISH MULTICENTRE STUDY

THE EFFECT OF LACTOBACILLUS REUTERI-CONTAINING QUADRUPLE THERAPY IN FIRST-LINE ERADICATION THERAPY FOR HELICOBACTER PYLORI INFECTION: A SINGLE-CENTER OPEN-LABEL RANDOMIZED CONTROLLED STUDY
THE EFFECT OF LACTOBACILLUS REUTERI-CONTAINING QUADRUPLE THERAPY IN FIRST-LINE ERADICATION THERAPY FOR HELICOBACTER PYLORI INFECTION: A SINGLE-CENTER OPEN-LABEL RANDOMIZED CONTROLLED STUDY

ALCOHOL INCREASES TREATMENT FAILURE FOR HELICOBACTER PYLORI ERADICATIONIN ASIAN POPULATIONS
ALCOHOL INCREASES TREATMENT FAILURE FOR HELICOBACTER PYLORI ERADICATIONIN ASIAN POPULATIONS

ALCOHOL INCREASES TREATMENT FAILURE FOR HELICOBACTER PYLORI ERADICATIONIN ASIAN POPULATIONS
ALCOHOL INCREASES TREATMENT FAILURE FOR HELICOBACTER PYLORI ERADICATIONIN ASIAN POPULATIONS

H. pylori (Posters)  et al.

THE EFFECT OF LACTOBACILLUS REUTERI-CONTAINING QUADRUPLE THERAPY IN FIRST-LINE ERADICATION THERAPY FOR HELICOBACTER PYLORI INFECTION: A SINGLE-CENTER OPEN-LABEL RANDOMIZED CONTROLLED STUDY
THE EFFECT OF LACTOBACILLUS REUTERI-CONTAINING QUADRUPLE THERAPY IN FIRST-LINE ERADICATION THERAPY FOR HELICOBACTER PYLORI INFECTION: A SINGLE-CENTER OPEN-LABEL RANDOMIZED CONTROLLED STUDY

H. pylori (Posters)  et al.

EVALUATION OF THE ACCURACY OF THE "LIAISON(R) MERIDIAN HELICOBACTER PYLORI SA" STOOL ANTIGEN TEST FOR THE DIAGNOSIS OF H. PYLORI INFECTION: A SPANISH MULTICENTRE STUDY
EVALUATION OF THE ACCURACY OF THE "LIAISON(R) MERIDIAN HELICOBACTER PYLORI SA" STOOL ANTIGEN TEST FOR THE DIAGNOSIS OF H. PYLORI INFECTION: A SPANISH MULTICENTRE STUDY

H. pylori (Posters)  et al.

OPTIMIZATION OF VONOPRAZAN-AMOXICILLIN DUAL THERAPY FOR ERADICATING HELICOBACTER PYLORI INFECTION IN CHINA: A PROSPECTIVE, RANDOMIZED CLINICAL PILOT STUDY
OPTIMIZATION OF VONOPRAZAN-AMOXICILLIN DUAL THERAPY FOR ERADICATING HELICOBACTER PYLORI INFECTION IN CHINA: A PROSPECTIVE, RANDOMIZED CLINICAL PILOT STUDY

H. pylori (Posters)  et al.

ALTERED GUT MICROBIOTA AND SHORT-CHAIN FATTY ACIDS AFTER VONOPRAZAN-AMOXICILLIN DUAL THERAPY FOR HELICOBACTER PYLORI ERADICATION
ALTERED GUT MICROBIOTA AND SHORT-CHAIN FATTY ACIDS AFTER VONOPRAZAN-AMOXICILLIN DUAL THERAPY FOR HELICOBACTER PYLORI ERADICATION

H. pylori (Posters)  et al.

PREVALENCE OF HELICOBACTER PYLORI IN OBESE PATIENTS UNDERGOING PREOPERATIVE ENDOSCOPIC EVALUATION FOR BARIATRIC SURGERY: EXPERIENCE FROM A SINGLE CENTER IN NORTHERN ITALY
PREVALENCE OF HELICOBACTER PYLORI IN OBESE PATIENTS UNDERGOING PREOPERATIVE ENDOSCOPIC EVALUATION FOR BARIATRIC SURGERY: EXPERIENCE FROM A SINGLE CENTER IN NORTHERN ITALY

H. pylori (Posters)  et al.

COMPARISON OF THE EFFECTIVENESS OF HELICOBACTER PYLORI ERADICATION REGIMENS BETWEEN THE ELDERLY AND NON-ELDERLY POPULATIONS: DATA FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)
COMPARISON OF THE EFFECTIVENESS OF HELICOBACTER PYLORI ERADICATION REGIMENS BETWEEN THE ELDERLY AND NON-ELDERLY POPULATIONS: DATA FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)

H. pylori (Posters)  et al.

EVALUATION OF IL-17F A7488G POLYMORPHISM IN HELICOBACTER PYLORI-INFECTED PATIENTS IN QOM-IRAN
EVALUATION OF IL-17F A7488G POLYMORPHISM IN HELICOBACTER PYLORI-INFECTED PATIENTS IN QOM-IRAN

H. pylori (Posters)  et al.

A PHASE 1, DOUBLE-BLIND, PARALLEL-GROUP STUDY TO EVALUATE THE PHARMACOKINETICS, SAFETY AND TOLERABILITY OF VONOPRAZAN- OR ESOMEPRAZOLE-BASED BISMUTH-CONTAINING QUADRUPLE THERAPY FOR HELICOBACTER PYLORI ERADICATION IN CHINA
A PHASE 1, DOUBLE-BLIND, PARALLEL-GROUP STUDY TO EVALUATE THE PHARMACOKINETICS, SAFETY AND TOLERABILITY OF VONOPRAZAN- OR ESOMEPRAZOLE-BASED BISMUTH-CONTAINING QUADRUPLE THERAPY FOR HELICOBACTER PYLORI ERADICATION IN CHINA

H. pylori (Posters)  et al.

ROLE OF COMPLIANCE IN HELICOBACTER PYLORI TREATMENTS: RESULTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)
ROLE OF COMPLIANCE IN HELICOBACTER PYLORI TREATMENTS: RESULTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)

H. pylori (Posters)  et al.

EMPIRIC "THREE-IN-ONE" BISMUTH QUADRUPLE THERAPY FOR HELICOBACTER PYLORI ERADICATION IN THE SECOND LINE: A PROSPECTIVE STUDY IN SOUTHERN ITALY
EMPIRIC "THREE-IN-ONE" BISMUTH QUADRUPLE THERAPY FOR HELICOBACTER PYLORI ERADICATION IN THE SECOND LINE: A PROSPECTIVE STUDY IN SOUTHERN ITALY

H. pylori (Posters)  et al.

ANTIBIOTIC RESISTANCE OF HELICOBACTER PYLORI IN PRIMARY CARE: AN OBSERVATIONAL COHORT STUDY
ANTIBIOTIC RESISTANCE OF HELICOBACTER PYLORI IN PRIMARY CARE: AN OBSERVATIONAL COHORT STUDY

H. pylori (Posters)  et al.

EFFECT OF METRONIDAZOLE RESISTANCE ON HELICOBACTER PYLORI ERADICATION REGIMENS
EFFECT OF METRONIDAZOLE RESISTANCE ON HELICOBACTER PYLORI ERADICATION REGIMENS

H. pylori (Posters)  et al.

EFFECTIVENESS AND SAFETY OF HIGH-DOSE DUAL THERAPY: RESULTS OF THE EUROPEAN REGISTRY ON HELICOBACTER PYLORI MANAGEMENT (HP-EUREG)
EFFECTIVENESS AND SAFETY OF HIGH-DOSE DUAL THERAPY: RESULTS OF THE EUROPEAN REGISTRY ON HELICOBACTER PYLORI MANAGEMENT (HP-EUREG)

H. pylori (Posters)  et al.

DIFFERENCES OF HELICOBACTER PYLORI DIAGNOSTICS AND TREATMENTS IN THE ELDERLY AND NON-ELDERLY POPULATIONS: DATA FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)
DIFFERENCES OF HELICOBACTER PYLORI DIAGNOSTICS AND TREATMENTS IN THE ELDERLY AND NON-ELDERLY POPULATIONS: DATA FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)

H. pylori (Posters)  et al.

HOW ARE JAPANESE PATIENTS WITH AUTOIMMUNE GASTRITIS AFFECTED BY H. PYLORI INFECTION?: AN EVALUATION OF SEROLOGICAL, ENDOSCOPIC, AND HISTOLOGICAL FINDINGS
HOW ARE JAPANESE PATIENTS WITH AUTOIMMUNE GASTRITIS AFFECTED BY H. PYLORI INFECTION?: AN EVALUATION OF SEROLOGICAL, ENDOSCOPIC, AND HISTOLOGICAL FINDINGS

H. pylori (Posters)  et al.

Item 21 - 40 / 48
1
2
3